Send to

Choose Destination
Neurobiol Aging. 2014 May;35(5):1012-23. doi: 10.1016/j.neurobiolaging.2013.10.089. Epub 2013 Oct 29.

Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease.

Author information

Department of Pharmacology, University of Melbourne, Melbourne, Victoria, Australia.
Synaptic Neurobiology Laboratory, Mental Health Research Institute, Melbourne, Victoria, Australia.
Department of Pharmacology, University of Melbourne, Melbourne, Victoria, Australia. Electronic address:


A neuro-inflammatory response has been implicated in human patients and animal models of Alzheimer's disease (AD). Type-1 interferons are pleiotropic cytokines involved in the initiation and regulation of the pro-inflammatory response; however, their role in AD is unknown. This study investigated the contribution of type-1 IFN signaling in the neuro-inflammatory response to amyloid-beta (Aβ) in vitro and in the APP/PS1 transgenic mouse model of AD. Enzyme-linked immunosorbent assay confirmed a 2-fold increase in IFNα in APP/PS1 brains compared with control brains. Quantitative polymerase chain reaction also identified increased IFNα and IFNβ expression in human pre-frontal cortex from AD patients. In vitro studies in primary neurons demonstrated Aβ-induced type-1 IFN expression preceded that of other classical pro-inflammatory cytokines, IL1-β, and IL-6. Significantly, ablation of type-1 interferon-α receptor 1 expression in BE(2)M17 neuroblastoma cells and primary neurons afforded protection against Aβ-induced toxicity. This study supports a role for type-1 interferons in the pro-inflammatory response and neuronal cell death in AD and suggests that blocking type-1 interferon-α receptor 1 maybe a therapeutic target to limit the disease progression.


Alzheimer's disease; Interleukin-1β; Interleukin-6; JAK-Stat; Neuro-inflammation; Type-1 interferons

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center